Different methods have been used to identify the CSCs in colorectal cancer [29–31], and the isolated subpopulation of CD44+/CD133+ cells from human colorectal cancer has been confirmed to be characterized as CSCs [31]. This evidence concerns the gene CD44 and colorectal cancer.